论文部分内容阅读
高脂血症是冠心病的重要危险因素。调脂治疗是预防冠心病事件的主要治疗手段之一。本组应用小剂量辛伐他丁 (舒降之 ,杭州默沙东制药有限公司产品 )对冠心病血脂异常患者进行治疗 ,评价其疗效与副作用。1 资料与方法1.1 研究对象 1998年 7月～ 1999年 10月收入我院心内科治
Hyperlipidemia is an important risk factor for coronary heart disease. Lipid-lowering therapy is one of the main treatments to prevent coronary heart disease. This group of patients with small doses of simvastatin (Shu down, Hangzhou Merck East Pharmaceutical Co., Ltd.) on patients with coronary heart disease dyslipidemia to evaluate its efficacy and side effects. 1 Materials and Methods 1.1 The research object July 1998 ~ October 1999 income in our hospital cardiology treatment